AstraZeneca, Lilly, GSK, Novartis to speak at Biotech Transfer Conference, Oct 24-26, Philadelphia
GTC is pleased to welcome representatives of AstraZeneca, Eli Lilly, GlaxoSmithKline and Novartis Pharmaceuticals as speakers at the Biotechnology Transfer & Commercialization Conference.
- (1888PressRelease) July 20, 2012 - The program is scheduled October 24-26, 2012 in Philadelphia, PA.
Bringing together all market segments required to move biotechnology from concept to commercialization, the Conference will be a gathering place for deal makers. The pharmaceutical companies will discuss the technologies they are seeking, the deals they prefer and the relationships that best meet their needs in an interactive panel discussion.
In addition to pharmaceutical companies, research universities, biotech firms, venture capital investors, emerging innovators and foundations are included on the program agenda.
Bridging the gulf between early research and commercial drug development is at the heart of the Biotechnology Transfer & Commercialization Conference. Attendees are encouraged to be interactive participants in a program that offers insight and networking opportunities.
Please visit www.gtcinsight.com to view the entire roster of confirmed participants and agenda.
The Biotechnology Transfer & Commercialization Conference is part of the 8th Modern Drug Discovery and Development Summit.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam